IRSH: Elan Corporation PLC: Elan Announces the Appointment of Mr. John Given as General Counsel

  IRSH: Elan Corporation PLC: Elan Announces the Appointment of Mr. John Given
  as General Counsel

UK Regulatory Announcement

DUBLIN

Elan Corporation, plc (NYSE:ELN) today announced the appointment of Mr. John
Given as General Counsel with effect from 1 March, 2013. Mr. Given will report
to the CEO, serve as a member of Elan’s executive management team as well as
serve as advisor to the Chairman and the full Board. He will be based in
Elan’s Dublin headquarters office.

Mr. Given joins Elan from leading Irish law firm A&L Goodbody, where he was a
Senior Corporate Partner. During Mr. Given’s over twenty years in private
practice, his clients included many leading Irish and international
corporates, including a number in the life sciences sector. Mr. Given has
acted as Elan’s lead external counsel for over a decade, advising the company
on all of its corporate activity. During his tenure at A&L Goodbody, Mr. Given
occupied various leadership positions and was head of the M&A practice for
nine years, during which time A&L Goodbody was consistently ranked in
international league tables as the number 1 Irish transactional law firm.

Elan’s Chairman, Robert A. Ingram, and CEO, Kelly Martin, commented, “John is
a uniquely talented and highly accomplished professional with over 20 years of
relevant and in-depth experience in the global arena. His direct M&A expertise
and proven track record in both transactions and advisory – serving both
international and multi-sector clients - makes him an invaluable addition to
our executive team. He is joining us at an exciting time as we advance the
company – across multiple dimensions - following the recently announced
Tysabri restructuring.”

Messrs. Ingram and Martin concluded, “We have no doubt that the Board,
management team, employees, shareholders and industry partners will greatly
benefit from John’s exceptional expertise, integrity and leadership. We are
enthusiastic to have him join us to work across all aspects of our business”

About Elan

Elan is a biotechnology company, headquartered in Ireland, committed to making
a difference in the lives of patients and their families by dedicating itself
to bringing innovations in science to fill significant unmet medical needs
that continue to exist around the world. For additional information about
Elan, please visit http://www.elan.com.

Investor Relations:
Chris Burns, 800-252-3526
David Marshall, + 353-1-709-4444
or
Media Relations
Emer Reynolds, + 353-1-709-4022
Jonathan Birt, +44-751-559-7858
Jamie Tully, +1-212-687-8080

Contact:

Elan Corporation PLC